// App-Quantinova.ai

: Poor Clinical Outcome in Pediatric Immunotherapy Is Mediated By a Pre-Existing Overactive IL-18-IFNy Immune Phenotype

Researchers

Presenter

  • Katelyn Burleigh

Principal Investigators

  • Anna Kus

  • Alice Long

  • Michael C. Jensen

  • Seth Masters

  • James E Vince

  • Bobbie-Jo Webb-Robertson

  • Rebecca A Gardner

  • Heather Gustafson

Medical Centers

  • Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA

  • Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, WA

  • Pacific Northwest National Laboratory, Richland, WA

  • Benaroya Research Institute, Seattle, WA

  • Seattle Children's Therapeutics, Seattle Children's Research Institute, Seattle, WA

  • The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

Locations

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 19

  • Coxsackie Virus And Adenovirus Receptor

  • Twist-related protein 1

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved